BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kamegaya Y, Hiasa Y, Zukerberg L, Fowler N, Blackard JT, Lin W, Choe WH, Schmidt EV, Chung RT. Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis. Hepatology. 2005;41:660-667. [PMID: 15723444 DOI: 10.1002/hep.20621] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Li Y, Tang ZY, Hou JX. Hepatocellular carcinoma: insight from animal models. Nat Rev Gastroenterol Hepatol. 2012;9:32-43. [PMID: 22025031 DOI: 10.1038/nrgastro.2011.196] [Cited by in Crossref: 79] [Cited by in F6Publishing: 73] [Article Influence: 7.9] [Reference Citation Analysis]
2 Abdallah C, Lejamtel C, Benzoubir N, Battaglia S, Sidahmed-Adrar N, Desterke C, Lemasson M, Rosenberg AR, Samuel D, Bréchot C, Pflieger D, Le Naour F, Bourgeade MF. Hepatitis C virus core protein targets 4E-BP1 expression and phosphorylation and potentiates Myc-induced liver carcinogenesis in transgenic mice. Oncotarget 2017;8:56228-42. [PMID: 28915586 DOI: 10.18632/oncotarget.17280] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
3 Fischer R, Baumert T, Blum HE. Hepatitis C virus infection and apoptosis. World J Gastroenterol. 2007;13:4865-4872. [PMID: 17828818 DOI: 10.3748/wjg.v13.i36.4865] [Cited by in CrossRef: 85] [Cited by in F6Publishing: 85] [Article Influence: 6.5] [Reference Citation Analysis]
4 Ioannou GN, Green P, Lowy E, Mun EJ, Berry K. Differences in hepatocellular carcinoma risk, predictors and trends over time according to etiology of cirrhosis. PLoS One 2018;13:e0204412. [PMID: 30260995 DOI: 10.1371/journal.pone.0204412] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 9.7] [Reference Citation Analysis]
5 Honma Y, Miyagawa K, Hara Y, Hayashi T, Kusanaga M, Ogino N, Minami S, Oe S, Ikeda M, Hino K, Harada M. Correlation of hepatitis C virus-mediated endoplasmic reticulum stress with autophagic flux impairment and hepatocarcinogenesis. Med Mol Morphol 2021;54:108-21. [PMID: 33386512 DOI: 10.1007/s00795-020-00271-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Feldmann G. L’apoptose hépatique. Gastroentérologie Clinique et Biologique 2006;30:533-45. [DOI: 10.1016/s0399-8320(06)73222-5] [Cited by in Crossref: 6] [Article Influence: 0.4] [Reference Citation Analysis]
7 De Minicis S, Kisseleva T, Francis H, Baroni GS, Benedetti A, Brenner D, Alvaro D, Alpini G, Marzioni M. Liver carcinogenesis: rodent models of hepatocarcinoma and cholangiocarcinoma. Dig Liver Dis 2013;45:450-9. [PMID: 23177172 DOI: 10.1016/j.dld.2012.10.008] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 6.4] [Reference Citation Analysis]
8 Tsai WL, Chung RT. Viral hepatocarcinogenesis. Oncogene 2010;29:2309-24. [PMID: 20228847 DOI: 10.1038/onc.2010.36] [Cited by in Crossref: 184] [Cited by in F6Publishing: 166] [Article Influence: 16.7] [Reference Citation Analysis]
9 Lin YL, Li Y. Study on the hepatocellular carcinoma model with metastasis. Genes Dis 2020;7:336-50. [PMID: 32884988 DOI: 10.1016/j.gendis.2019.12.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Cho K, Ro SW, Seo SH, Jeon Y, Moon H, Kim DY, Kim SU. Genetically Engineered Mouse Models for Liver Cancer. Cancers (Basel) 2019;12:E14. [PMID: 31861541 DOI: 10.3390/cancers12010014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
11 Hammam O, Mahmoud O, Zahran M, Aly S, Hosny K, Helmy A, Anas A. The role of fas/fas ligand system in the pathogenesis of liver cirrhosis and hepatocellular carcinoma. Hepat Mon. 2012;12:e6132. [PMID: 23300494 DOI: 10.5812/hepatmon.6132] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
12 Guntaka RV, Padala MK. Interaction of Hepatitis C Viral Proteins with Cellular Oncoproteins in the Induction of Liver Cancer. ISRN Virology 2014;2014:1-11. [DOI: 10.1155/2014/351407] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Klopstock N, Katzenellenbogen M, Pappo O, Sklair-Levy M, Olam D, Mizrahi L, Potikha T, Galun E, Goldenberg D. HCV tumor promoting effect is dependent on host genetic background. PLoS One. 2009;4:e5025. [PMID: 19340302 DOI: 10.1371/journal.pone.0005025] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
14 Wu L, Tang Z, Li Y. Experimental models of hepatocellular carcinoma: developments and evolution. J Cancer Res Clin Oncol 2009;135:969-81. [DOI: 10.1007/s00432-009-0591-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
15 Butt AS, Sharif F, Abid S. Impact of direct acting antivirals on occurrence and recurrence of hepatocellular carcinoma: Biologically plausible or an epiphenomenon? World J Hepatol 2018;10:267-76. [PMID: 29527262 DOI: 10.4254/wjh.v10.i2.267] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
16 Jang JY, Chung RT. Chronic hepatitis C. Gut Liver. 2011;5:117-132. [PMID: 21814590 DOI: 10.5009/gnl.2011.5.2.117] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
17 Koike K, Moriya K, Matsuura Y. Animal models for hepatitis C and related liver disease. Hepatol Res 2010;40:69-82. [PMID: 20156300 DOI: 10.1111/j.1872-034X.2009.00593.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
18 Lerat H, Higgs M, Pawlotsky JM. Animal models in the study of hepatitis C virus-associated liver pathologies. Expert Rev Gastroenterol Hepatol. 2011;5:341-352. [PMID: 21651352 DOI: 10.1586/egh.11.14] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
19 Wang Q, Zhang P, Li Z, Feng X, Lv C, Zhang H, Xiao H, Ding J, Chen X. Evaluation of Polymer Nanoformulations in Hepatoma Therapy by Established Rodent Models. Theranostics 2019;9:1426-52. [PMID: 30867842 DOI: 10.7150/thno.31683] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 17.5] [Reference Citation Analysis]
20 Tumurbaatar B, Sun Y, Chan T, Sun J. Cre-estrogen receptor-mediated hepatitis C virus structural protein expression in mice. J Virol Methods. 2007;146:5-13. [PMID: 17628708 DOI: 10.1016/j.jviromet.2007.05.025] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
21 Liu C. Hepatitis C Virus: Virology and Experimental Systems. Clinics in Liver Disease 2006;10:773-91. [DOI: 10.1016/j.cld.2006.08.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
22 He L, Tian DA, Li PY, He XX. Mouse models of liver cancer: Progress and recommendations. Oncotarget 2015;6:23306-22. [PMID: 26259234 DOI: 10.18632/oncotarget.4202] [Cited by in Crossref: 50] [Cited by in F6Publishing: 54] [Article Influence: 10.0] [Reference Citation Analysis]
23 Lee SH, Song R, Lee MN, Kim CS, Lee H, Kong YY, Kim H, Jang SK. A molecular chaperone glucose-regulated protein 94 blocks apoptosis induced by virus infection. Hepatology. 2008;47:854-866. [PMID: 18273841 DOI: 10.1002/hep.22107] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
24 Delgado-Borrego A, Kamegaya Y, Jordan SH, Agrawal S, Valim C, Chung RT. HCV synergizes with body weight in the promotion of insulin resistance. J Viral Hepat 2011;18:135-41. [PMID: 20497310 DOI: 10.1111/j.1365-2893.2010.01291.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
25 Alter H. Viral hepatitis. Hepatology 2006;43:S230-4. [DOI: 10.1002/hep.21030] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
26 McGivern DR, Lemon SM. Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer. Oncogene. 2011;30:1969-1983. [PMID: 21258404 DOI: 10.1038/onc.2010.594] [Cited by in Crossref: 136] [Cited by in F6Publishing: 130] [Article Influence: 13.6] [Reference Citation Analysis]
27 Brown ZJ, Heinrich B, Greten TF. Mouse models of hepatocellular carcinoma: an overview and highlights for immunotherapy research. Nat Rev Gastroenterol Hepatol 2018;15:536-54. [DOI: 10.1038/s41575-018-0033-6] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 23.3] [Reference Citation Analysis]
28 Jiao J, Wang J, Sallberg M. Effects of HCV proteins in current HCV transgenic models. Hepatology Research 2010;40:115-24. [DOI: 10.1111/j.1872-034x.2009.00574.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
29 Leenders MW, Nijkamp MW, Borel Rinkes IH. Mouse models in liver cancer research: a review of current literature. World J Gastroenterol. 2008;14:6915-6923. [PMID: 19058325 DOI: 10.3748/wjg.14.6915] [Cited by in CrossRef: 55] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
30 Billerbeck E, de Jong Y, Dorner M, de la Fuente C, Ploss A. Animal models for hepatitis C. Curr Top Microbiol Immunol. 2013;369:49-86. [PMID: 23463197 DOI: 10.1007/978-3-642-27340-7_3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 49] [Article Influence: 3.0] [Reference Citation Analysis]
31 Vercauteren K, de Jong YP, Meuleman P. HCV animal models and liver disease. J Hepatol 2014;61:S26-33. [PMID: 25443343 DOI: 10.1016/j.jhep.2014.07.013] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
32 Willimsky G, Schmidt K, Loddenkemper C, Gellermann J, Blankenstein T. Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance. J Clin Invest. 2013;123:1032-1043. [PMID: 23454765 DOI: 10.1172/jci64742] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 3.9] [Reference Citation Analysis]
33 Amarapurkar D, Han K, Chan HL, Ueno Y; The Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma. Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region. Journal of Gastroenterology and Hepatology 2009;24:955-61. [DOI: 10.1111/j.1440-1746.2009.05805.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 4.3] [Reference Citation Analysis]
34 Meuleman P, Leroux-Roels G. HCV animal models: a journey of more than 30 years. Viruses 2009;1:222-40. [PMID: 21994547 DOI: 10.3390/v1020222] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
35 Ueno Y, Sollano JD, Farrell GC. Prevention of hepatocellular carcinoma complicating chronic hepatitis C. J Gastroenterol Hepatol 2009;24:531-6. [PMID: 19368633 DOI: 10.1111/j.1440-1746.2009.05814.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
36 Zemel R, Issachar A, Tur-kaspa R. The Role of Oncogenic Viruses in the Pathogenesis of Hepatocellular Carcinoma. Clinics in Liver Disease 2011;15:261-79. [DOI: 10.1016/j.cld.2011.03.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
37 Khaliq S, Jahan S, Ijaz B, Ahmad W, Asad S, Hassan S. Inhibition of hepatitis C virus genotype 3a by siRNAs targeting envelope genes. Arch Virol 2011;156:433-42. [PMID: 21161551 DOI: 10.1007/s00705-010-0887-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
38 Molina-sánchez P, Lujambio A. Experimental Models for Preclinical Research in Hepatocellular Carcinoma. In: Hoshida Y, editor. Hepatocellular Carcinoma. Cham: Springer International Publishing; 2019. pp. 333-58. [DOI: 10.1007/978-3-030-21540-8_16] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
39 Takahashi Y, Fukusato T. Animal Models of Liver Diseases. Animal Models for the Study of Human Disease. Elsevier; 2017. pp. 313-39. [DOI: 10.1016/b978-0-12-809468-6.00013-9] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
40 Kremsdorf D, Brezillon N. New animal models for hepatitis C viral infection and pathogenesis studies. World J Gastroenterol 2007;13:2427-35. [PMID: 17552025 DOI: 10.3748/wjg.v13.i17.2427] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
41 Newell P, Villanueva A, Friedman SL, Koike K, Llovet JM. Experimental models of hepatocellular carcinoma. J Hepatol. 2008;48:858-879. [PMID: 18314222 DOI: 10.1016/j.jhep.2008.01.008] [Cited by in Crossref: 150] [Cited by in F6Publishing: 137] [Article Influence: 11.5] [Reference Citation Analysis]
42 Barth H, Robinet E, Liang TJ, Baumert TF. Mouse models for the study of HCV infection and virus-host interactions. J Hepatol. 2008;49:134-142. [PMID: 18457898 DOI: 10.1016/j.jhep.2008.03.012] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 3.2] [Reference Citation Analysis]
43 Heindryckx F, Colle I, Van Vlierberghe H. Experimental mouse models for hepatocellular carcinoma research. Int J Exp Pathol. 2009;90:367-386. [PMID: 19659896 DOI: 10.1111/j.1365-2613.2009.00656.x] [Cited by in Crossref: 232] [Cited by in F6Publishing: 202] [Article Influence: 19.3] [Reference Citation Analysis]
44 Ioannou GN, Feld JJ. What Are the Benefits of a Sustained Virologic Response to Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection? Gastroenterology. 2019;156:446-460.e2. [PMID: 30367836 DOI: 10.1053/j.gastro.2018.10.033] [Cited by in Crossref: 81] [Cited by in F6Publishing: 75] [Article Influence: 27.0] [Reference Citation Analysis]
45 Mitchell JK, McGivern DR. Mechanisms of hepatocarcinogenesis in chronic hepatitis C. Hepat Oncol 2014;1:293-307. [PMID: 30190964 DOI: 10.2217/hep.14.7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
46 Chiou HL, Hsieh YS, Hsieh MR, Chen TY. HCV E2 may induce apoptosis of Huh-7 cells via a mitochondrial-related caspase pathway. Biochem Biophys Res Commun. 2006;345:453-458. [PMID: 16681997 DOI: 10.1016/j.bbrc.2006.04.118] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
47 Laskus T, Kibler KV, Chmielewski M, Wilkinson J, Adair D, Horban A, Stańczak G, Radkowski M. Effect of hepatitis C infection on HIV-induced apoptosis. PLoS One 2013;8:e75921. [PMID: 24098405 DOI: 10.1371/journal.pone.0075921] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
48 Yamane D, Mcgivern DR, Masaki T, Lemon SM. Liver Injury and Disease Pathogenesis in Chronic Hepatitis C. In: Bartenschlager R, editor. Hepatitis C Virus: From Molecular Virology to Antiviral Therapy. Berlin: Springer Berlin Heidelberg; 2013. pp. 263-88. [DOI: 10.1007/978-3-642-27340-7_11] [Cited by in Crossref: 12] [Cited by in F6Publishing: 33] [Article Influence: 1.5] [Reference Citation Analysis]
49 Fink SL, Jayewickreme TR, Molony RD, Iwawaki T, Landis CS, Lindenbach BD, Iwasaki A. IRE1α promotes viral infection by conferring resistance to apoptosis. Sci Signal 2017;10:eaai7814. [PMID: 28588082 DOI: 10.1126/scisignal.aai7814] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
50 Burm R, Collignon L, Mesalam AA, Meuleman P. Animal Models to Study Hepatitis C Virus Infection. Front Immunol 2018;9:1032. [PMID: 29867998 DOI: 10.3389/fimmu.2018.01032] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
51 Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6:674-687. [PMID: 16929323 DOI: 10.1038/nrc1934] [Cited by in Crossref: 1337] [Cited by in F6Publishing: 1263] [Article Influence: 89.1] [Reference Citation Analysis]